Aprogen Biologics Inc. (KRX:003060)

South Korea flag South Korea · Delayed Price · Currency is KRW
236.00
+1.00 (0.43%)
At close: Apr 8, 2026
Market Cap46.63B -68.6%
Revenue (ttm)73.23B +8.7%
Net Income-170.33B
EPS-862.00
Shares Out197.57M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume2,517,887
Average Volume3,451,137
Open235.00
Previous Close235.00
Day's Range234.00 - 242.00
52-Week Range233.00 - 748.00
Beta-0.09
RSI30.67
Earnings DateMay 13, 2026

About Aprogen Biologics

Aprogen Biologics Inc. manufactures and sells pharmaceutical products primarily in South Korea. The company was founded in 1960 and is headquartered in Seoul, South Korea. [Read more]

Sector Healthcare
Founded 1960
Employees 391
Stock Exchange Korea Stock Exchange
Ticker Symbol 003060
Full Company Profile

Financial Performance

In 2025, Aprogen Biologics's revenue was 73.23 billion, an increase of 8.68% compared to the previous year's 67.38 billion. Losses were -170.33 billion, 62.3% more than in 2024.

Financial Statements